The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

Pharmaceutical company GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

Curevo Vaccine raises $110M Series B for shingles vaccine trial extension, adds Moncef Slaoui as board chair and Moderna's ...

Reading a pamphlet in the doctor’s office about which vaccines to get may help nudge older adults to get vaccinated.

The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.

GSK plc (LON:GSK – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,444 ($18.73) and traded as high ...